{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:05:19Z","timestamp":1790676319728,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Current guideline recommendation to use escalating doses of loop diuretics in acute heart failure (AHF) is limited by worsening renal function and by diuretic resistance. There is an unmet need for novel therapeutic strategies to treat these patients. The aim of this study was to evaluate efficacy and safety of different combination diuretic strategies in patients with AHF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A systematic search identified 11 eligible randomized controlled trials involving 7517 patients. A combination diuretic strategy was not associated with reduction of all-cause death (relative risk [RR] 0.97, 95% confidence interval [CI] 0.89\u20131.07, p\u2009=\u20090.55) or heart failure (HF) events (RR 0.83, 95% CI 0.64\u20131.08, p\u2009=\u20090.16), but was associated with more weight loss (mean difference [MD]: \u22120.96, 95% CI \u22121.37 to \u22120.54, p\u2009&amp;lt;\u20090.0001) and diuretic efficiency (weight changes per mean daily loop diuretic dose) (MD: \u22120.56, 95% CI \u22121.11 to \u22120.02, p\u2009=\u20090.04), higher daily urinary output (MD 266.26, 95% CI 47.20\u2013485.32, p\u2009=\u20090.02). Sodium\u2013glucose co-transporter 2 inhibitor (SGLT2i) administration during hospitalization reduced HF events (RR 0.66, 95% CI 0.58\u20130.76, p\u2009&amp;lt;\u20090.0001) and the risk of worsening renal function (defined as an increase &amp;gt;0.3\u2009mg\/dl of serum creatinine and\/or a reduction &amp;gt;50% of the estimated glomerular filtration rate compared with baseline levels) (RR 0.69, 95% CI 0.50\u20130.96, p\u2009=\u20090.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with AHF, a combination diuretic strategy improved early decongestion without affecting prognosis. The use of SGLT2i during index hospitalization was associated with an improvement in all-cause mortality and HF events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.70094","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:02:43Z","timestamp":1765357363000},"page":"3096-3110","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combination Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"27","author":[{"given":"Francesco","family":"Fioretti","sequence":"first","affiliation":[{"name":"Baylor Scott & White Research Institute , Dallas, TX ,","place":["USA"]},{"name":"Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Praderio","sequence":"additional","affiliation":[{"name":"Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savina","family":"Nodari","sequence":"additional","affiliation":[{"name":"Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott & White Research Institute , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"2026021721521543900_ejhf70094-bib-0001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tcm.2019.03.007","article-title":"Acute heart failure","volume":"30","author":"Sinnenberg","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"2026021721521543900_ejhf70094-bib-0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10741-007-9008-3","article-title":"An introduction to acute heart failure syndromes: Definition and classification","volume":"12","author":"Filippatos","year":"2007","journal-title":"Heart Fail Rev"},{"key":"2026021721521543900_ejhf70094-bib-0003","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0004","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacc.2018.11.049","article-title":"Clinical course of patients with worsening heart failure with reduced ejection fraction","volume":"73","author":"Butler","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-019-09851-9","article-title":"Loop diuretic resistance complicating acute heart failure","volume":"25","author":"Cox","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2026021721521543900_ejhf70094-bib-0008","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","article-title":"Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study","volume":"8","author":"Tromp","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026021721521543900_ejhf70094-bib-0009","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2010.748","article-title":"Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006","volume":"303","author":"Bueno","year":"2010","journal-title":"JAMA"},{"key":"2026021721521543900_ejhf70094-bib-0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10741-019-09912-z","article-title":"Readmission-free period and in-hospital mortality at the time of first readmission in acute heart failure patients \u2013 NRD-based analysis of 40,000 heart failure readmissions","volume":"26","author":"Altibi","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2026021721521543900_ejhf70094-bib-0011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0012","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0013","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: The CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021721521543900_ejhf70094-bib-0014","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: The ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2026021721521543900_ejhf70094-bib-0016","doi-asserted-by":"crossref","first-page":"16474","DOI":"10.1038\/s41598-021-96002-6","article-title":"Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: A randomized clinical trial","volume":"11","author":"Piardi","year":"2021","journal-title":"Sci Rep"},{"key":"2026021721521543900_ejhf70094-bib-0017","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of dapagliflozin in patients with acute heart failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0018","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.602251","article-title":"Safety and efficacy of adding dapagliflozin to furosemide in type 2 diabetic patients with decompensated heart failure and reduced ejection fraction","volume":"7","author":"Ibrahim","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026021721521543900_ejhf70094-bib-0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"2026021721521543900_ejhf70094-bib-0020","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021721521543900_ejhf70094-bib-0021","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0023","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"2026021721521543900_ejhf70094-bib-0024","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026021721521543900_ejhf70094-bib-0025","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1161\/CIR.0000000000000523","article-title":"Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: A scientific statement from the American Heart Association","volume":"136","author":"Rao","year":"2017","journal-title":"Circulation"},{"key":"2026021721521543900_ejhf70094-bib-0026","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026021721521543900_ejhf70094-bib-0027","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026021721521543900_ejhf70094-bib-0028","first-page":"1","article-title":"Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study","author":"Hsu","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"2026021721521543900_ejhf70094-bib-0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2025.08.041","article-title":"Efficacy and safety of different combinations of add-on diuretic therapy in acute heart failure: A systematic review and network meta-analysis of randomized controlled trials","volume":"258","author":"Sephien","year":"2025","journal-title":"Am J Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0031","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2024.06.002","article-title":"2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: A report of the American College of Cardiology Solution Set Oversight Committee","volume":"84","author":"Hollenberg","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0032","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2024.01.029","article-title":"Enhanced decongestive therapy in patients with acute heart failure: JACC review topic of the week","volume":"83","author":"Cotter","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0033","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2026021721521543900_ejhf70094-bib-0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2023.04.002","article-title":"The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial","volume":"381","author":"Eder","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"2026021721521543900_ejhf70094-bib-0036","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0037","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjcard.2023.07.074","article-title":"Heart failure hospitalizations versus cardiovascular mortality in heart failure trials","volume":"203","author":"Kaul","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0038","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: A comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"2026021721521543900_ejhf70094-bib-0039","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-025-10548-5","article-title":"Pharmacological options to relieve congestion in acute heart failure","author":"Kapelios","year":"2025","journal-title":"Heart Fail Rev"},{"key":"2026021721521543900_ejhf70094-bib-0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-021-10157-y","article-title":"Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients","volume":"28","author":"Correale","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2026021721521543900_ejhf70094-bib-0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114310","article-title":"SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy","volume":"160","author":"Croteau","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026021721521543900_ejhf70094-bib-0042","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-7-1","article-title":"Emerging concepts in heart failure management and treatment: Focus on SGLT2 inhibitors in heart failure with preserved ejection fraction","volume":"12","author":"De Lorenzi","year":"2023","journal-title":"Drugs Context"},{"key":"2026021721521543900_ejhf70094-bib-0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2017.04.011","article-title":"Sodium-glucose co-transporters and their inhibition: Clinical physiology","volume":"26","author":"Ferrannini","year":"2017","journal-title":"Cell Metab"},{"key":"2026021721521543900_ejhf70094-bib-0044","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on water and sodium metabolism","volume":"13","author":"Tang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026021721521543900_ejhf70094-bib-0045","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0046","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082824","article-title":"Pleiotropic effects of sodium-glucose cotransporter-2 inhibitors in cardiovascular disease and chronic kidney disease","volume":"12","author":"Rastogi","year":"2023","journal-title":"J Clin Med"},{"key":"2026021721521543900_ejhf70094-bib-0047","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2169\/internalmedicine.1215-22","article-title":"Early initiation of dapagliflozin during hospitalization for acute heart failure is associated with a shorter hospital stay","volume":"62","author":"Mizobuchi","year":"2023","journal-title":"Intern Med"},{"key":"2026021721521543900_ejhf70094-bib-0048","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1536\/ihj.21-022","article-title":"Efficacy of continuing SGLT2 inhibitors on outcomes in patients with acute decompensated heart failure","volume":"62","author":"Nakagaito","year":"2021","journal-title":"Int Heart J"},{"key":"2026021721521543900_ejhf70094-bib-0049","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021721521543900_ejhf70094-bib-0050","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00392-022-02148-2","article-title":"Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: A meta-analysis of randomized controlled trials","volume":"112","author":"Carvalho","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0051","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0052","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.amjcard.2014.12.045","article-title":"Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial)","volume":"115","author":"Khan","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026021721521543900_ejhf70094-bib-0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012914","article-title":"Hypokalemia during decongestion with loop diuretics and hydrochlorothiazide, a post hoc analysis of the CLOROTIC trial","volume":"18","author":"Conde-Martel","year":"2025","journal-title":"Circ Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0054","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jchf.2024.05.006","article-title":"Combining loop and thiazide diuretics across the left ventricular ejection fraction spectrum: The CLOROTIC trial","volume":"12","author":"S\u00e1nchez-Marteles","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.109.899526","article-title":"Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: Findings from propensity-matched studies","volume":"3","author":"Bowling","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026021721521543900_ejhf70094-bib-0056","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cardfail.2022.05.011","article-title":"Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: A retrospective cohort study","volume":"28","author":"Cisowska","year":"2022","journal-title":"J Card Fail"},{"key":"2026021721521543900_ejhf70094-bib-0057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2024.12.010","article-title":"Patterns of diuretic titration during inpatient management of acute decompensated heart failure","volume":"282","author":"Bullock","year":"2025","journal-title":"Am Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/12\/3096\/66836407\/eurjhf_27_12_3096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/12\/3096\/66836407\/eurjhf_27_12_3096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:52:30Z","timestamp":1771383150000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/12\/3096\/8470640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,10]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.70094","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"2024-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}